Drug Discovery

Oral Cambinol Treatment Shows Potential for Blocking Development of AD

Alzheimer's disease researchers have shown that the low molecular weight drug cambinol blocks the formation of exosomes that allow the spread of insoluble, toxic tau aggregates, which are characteristic of the neurodegenerative disorder.

Latest Drug Discovery News




GLOBETECH PUBLISHING LLC